It was also revealed that OM-MSC-EVs promote HIF-1α-VEGF signaling in HBMECs through the miR-612-TP53-HIF-1α-VEGF axis, therefore suggesting that H-EVs serve as a promising alternative treatment for ischemic disease. The gene discussed is HIF1A; the disease is ocular melanoma.